Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The current status of orphan drugs management in taiwan

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: HSIEH, Yow-Wen (China Medical University Hospital, Pharmacy, Taichung, China Taiwan)
  • Co-author(s): Cheng, Yih-Dih (China Medical University Hospital, Taichung, China Taiwan)
    Deng, Shin-Tarng (Linkou Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
    Jiang, Ruey-Ling (Da Chien General Hospital, Miaoli city, China Taiwan)
    Lai, Ya-Yun (National Tainan Junior College of Nursing, Tainan, China Taiwan)
    Chi, Jo-Feng (Food and Drug Administration, Ministry of Health and Welfare, Taipei, China Taiwan)
    Huang, Shu-Ping (Food and Drug Administration, Ministry of Health and Welfare, Taipei, China Taiwan)
  • Abstract:

    Abstract
    Background:
    In recent years, rare disease is an important public health issue and a challenge to medical care. In addition to devoted to develop the treatments of rare diseases, we also have formulated management regulation. Until March, 2014, a total of 201 orphan diseases and 85 orphan drugs have been defined, and 40 different formulas..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses